Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 144

Omnicell, Inc.

OMCLNASDAQEQUITYCurrent

SEC Filing

Filed Aug 17, 2026Accepted Aug 17, 2026, 10:08 AM EDTCIK 926326Accession 0001959173-26-006055
Share

Company context

Since 1992, Omnicell has been committed to delivering innovative, outcomes-centric pharmacy and nursing solutions for all settings of care. As an intelligent medication management technology company, Omnicell empowers autonomous medication management by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that improve efficiency and enhance patient safety for healthcare facilities worldwide. Learn more at omnicell.com.

Current securities

Recent company filings

  1. SCHEDULE 13G/A filingAug 10, 2026
  2. 10-Q filingAug 5, 2026
  3. Results of Operations and Financial ConditionJul 30, 2026
  4. 144 filingJul 15, 2026
  5. S-8 filingJul 7, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗